Phase 1/2 Study of the Timing and Efficacy of 3 mg Peg-GCSF in Neo/Adjuvant Dose Dense Breast Cancer Treatment Protocols

Background  Peg-GCSF has similar efficacy at a dose of 60 µg/kg and 100 µg/kg. The conventional 6 mg SC dose was based on the maximum tolerable dose. In Japan, 3.6 mg dose was approved on the basis of dose finding studies. Peg-GCSF is an integral part of dose-dense chemotherapy protocols. Dose findi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Amol, Pathak, Abhishek, Sarin, Arti, Shelly, Divya, Ranjan, Richa, Singh, Arashdeep, Kala, Tripti, PV, Babitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691905/
https://www.ncbi.nlm.nih.gov/pubmed/38047054
http://dx.doi.org/10.1055/s-0042-1757599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691905/
https://www.ncbi.nlm.nih.gov/pubmed/38047054
http://dx.doi.org/10.1055/s-0042-1757599

Ejemplares similares